Image

The KN510713 Study in Combination With mFOLFIRINOX

Join the KN510713 Study with mFOLFIRINOX for pancreatic cancer research.

Recruiting
19-75 years
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study examines a new drug, **KN510713**, combined with **mFOLFIRINOX**, a chemotherapy treatment for advanced pancreatic cancer. The study has two parts: finding the right dose and expanding to more people. Participants need to be 19 to 75 years old, have a confirmed diagnosis of advanced pancreatic cancer, and must be able to start mFOLFIRINOX treatment. Some medical conditions, previous treatments, or certain medications may disqualify you from participating. The study aims to see if the new drug is safe and effective.

  • Duration: The study involves ongoing participation with regular check-ups.
  • Visits: Participants will need to visit the study center for treatments and monitoring.
  • Risks: There may be side effects from the new drug and chemotherapy.
Print
Study details
    Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

NCT07114861

New Cancer Cure-Bio Co.,Ltd.

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.